Veraxa Biotech AG (VRXA) Insider Trading

Veraxa Biotech AG (VRXA) has 2 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $83K. Most recent filing: Aug. 31, 2026.

Filings
2
Purchases
2
$83K
Sales
0
$0
Insiders
2

Most active VRXA insiders

Baumann Oliver Rolf
Director
1 bought · 0 sold · Aug. 31, 2026
$75K
Antz Christoph Rudiger
Chief Executive Officer
1 bought · 0 sold · Aug. 31, 2026
$8K

Latest VRXA Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
Aug. 31, 2026 filed Aug. 27, 2026 Antz Christoph Rudiger Chief Executive Officer +$7,650 5,000 New No
Aug. 31, 2026 filed Aug. 27, 2026 Baumann Oliver Rolf Director +$75,000 50,000 +1% No

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when VRXA insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free